Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences

DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that chief executive officer, Anshul Thakral, chief financial officer, Jill McConnell, and senior vice president of investor relations, Tracy Krumme, will participate in the following conferences in December:

Citi Global Healthcare Conference (Miami)
Date: Tuesday, December 2, 2025
Time: 1:00 pm ET
Format: Fireside Chat
Webcast: FTRE Citi webcast
 
Evercore 8th Annual Healthcare Conference (Miami)
Date:
Wednesday, December 3, 2025
Time:
10:50 am ET
Format:
Fireside Chat
Webcast:
FTRE Evercore webcast
 

The live webcasts and replay of the fireside chats will be accessible through the “Events” section of Fortrea’s  Investor Relations website. Investors interested in one-on-one meetings should contact their banking representatives.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

Staff

Recent Posts

Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF)…

1 hour ago

Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study

Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through…

2 hours ago

MOVA Life brings its smart health home vision to Silicon Valley

SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- Global smart technology brand MOVA hosted its…

2 hours ago

LEADOPTIK Announces FDA Clearance of the LIA™ for Lung Biopsy Procedures

SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- LEADOPTIK, Inc. today announced U.S. Food and…

2 hours ago

BODYWELLE Now Offers FDA-Approved Oral Wegovy, the First Oral GLP-1 for Medical Weight Management

The Miami Beach-based practice integrates the newly approved oral GLP-1 into its physician-supervised weight management…

2 hours ago

NCQA Appoints Dana Erickson and Kate McEvoy to Board of Directors

Nationally recognized healthcare leaders will bring fresh insight to advance NCQA's work in quality and…

2 hours ago